DRMA · Dermata Therapeutics, Inc. · Exempt Offerings
$0.76
+0.00 (+0.28%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$3.07M
Shares
4.02M
Volume · Nov 6
60.22K
Avg daily vol (3M)
3.39M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-01-07 | New | Biotechnology | $4,124,591 | $4,124,591 | 06b |
| 2025-02-04 | Amendment | Other Technology | $2,550,000 | $2,550,000 | 06b |
| 2025-01-28 | New | Other Technology | $2,550,000 | $2,550,000 | 06b |
| 2024-09-27 | New | Other Technology | $3,498,089 | $3,498,089 | 06b |
| 2023-06-12 | New | Other Technology | Indefinite | $0 | 06b |
Showing 1–5 of 5 filings